Jan 6 (Reuters) - Revance Therapeutics Inc ( RVNC ):
* TEOXANE SA ANNOUNCES SUPERIOR PROPOSAL TO ACQUIRE REVANCE
THERAPEUTICS FOR $3.60 PER SHARE IN CASH
* TEOXANE: PREPARED TO TRANSACT PROMPTLY
* TEOXANE: DOES NOT ANTICIPATE ANY SIGNIFICANT REGULATORY
RISKS OR
DELAYS FOR POTENTIAL REVANCE DEAL
Source text:
Further company coverage: